Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-13

Clinical Trial Update: To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise [Phase 2]

View source ↗

Summary

The document announces a Phase 2 clinical trial evaluating the efficacy and safety of HD-6277 in adults with type 2 diabetes mellitus who have inadequate glycem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HD-6277

Snippet

Sponsor: Hyundai Pharm | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: RECRUITING